Accu-Chek Connect Diabetes Management App
Published February 1, 2017 · Recall initiated: December 20, 2016
Summary
FDA records medical device Class II recall Z-1099-2017, published February 1, 2017 and initiated December 20, 2016. Recalling firm: Roche Diabetes Care, Inc.; Status: Terminated; Reported quantity: 27243; Lot: Catalog number 07562462001 / GTIN number 00365702700000 Catalog number 07250452001 / GTIN number 00365702700017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
iOS and Android: Under certain conditions the affected app versions may disregard historical bolus data potentially leading to an incorrect bolus insulin recommendation being provided to the user. iOS only: Pairing and using multiple meters with the Accu-Chek Connect app can under rare circumstances cause the bolus advisor to fail to offer a correction bolus recommendation within the eligible time window following a blood glucose measurement (10 15 minutes). Depending on the individual metabolic situation potentially incorrect bolus advice could lead to serious health consequences such as hypoglycemia. Both software issues may also cause the amount of active insulin displayed during the bolus calculation process to be incorrect and should not be used to manually calculate a bolus.
What to do
Voluntary: Firm initiated · Other
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Roche Diabetes Care, Inc.
- Distributor
- Worldwide Distribution - Nationwide Distribution The Accu-Chek Connect App for iOS is distributed directly to end users via the Apple App Store. The Accu-Chek Connect App for Android is distributed directly to end users via the Google Play App Store.
- Lot
- Catalog number 07562462001 / GTIN number 00365702700000 Catalog number 07250452001 / GTIN number 00365702700017
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAccu-Chek Guide (SC) Kit -Intended to quantitatively measure glucose in fresh capillary whole blood from theJuly 3, 2024
- FDAAccu-Chek Aviva Plus Health Network Strips- intended for Blood Glucose Monitoring System Catalog Number:February 12, 2020
- FDAAccu-Chek Aviva Plus Retail Strips 50 ct - intended for Blood Glucose Monitoring System Catalog Number:February 12, 2020
- FDAAccu-Chek Aviva II Meter - Product Usage: a. The Accu-Chek Aviva Plus Blood Glucose Monitoring System isOctober 9, 2019
- FDASoftbank software Product Usage: Decision support software for transfusion service. It keeps track ofFebruary 1, 2017
- FDAPhilips Cisco 3850 layer 3 switch, 865339 model WS-C3850-12S-E in use with IntelliVue Information Center iX orFebruary 1, 2017
Questions about this recall
Was Accu-Chek Connect Diabetes Management App recalled?
Yes. FDA published recall Z-1099-2017 on February 1, 2017. Reported hazard: iOS and Android: Under certain conditions the affected app versions may disregard historical bolus data potentially leading to an incorrect bolus insulin recommendation being provided to the user. iOS only: Pairing and using multiple meters with the Accu-Chek Connect app can under rare circumstances cause the bolus advisor to fail to offer a correction bolus recommendation within the eligible time window following a blood glucose measurement (10 15 minutes). Depending on the individual metabolic situation potentially incorrect bolus advice could lead to serious health consequences such as hypoglycemia. Both software issues may also cause the amount of active insulin displayed during the bolus calculation process to be incorrect and should not be used to manually calculate a bolus.
What should I do if I have this product?
Voluntary: Firm initiated · Other